Immunocore Holdings plc Trade And Other Current Payables To Trade Suppliers
Immunocore Holdings plc (IMCR) had Trade And Other Current Payables To Trade Suppliers of GBP 13.99 million as of 2023-06-30, per its 6-K filed 2023-08-10.
Discontinued › Notes
ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers · last filed 2023-08-10
- 2023-06-30: Trade And Other Current Payables To Trade Suppliers 13.99M GBP.
- 2022-12-31: Trade And Other Current Payables To Trade Suppliers 11.72M GBP.
- 2022-09-30: Trade And Other Current Payables To Trade Suppliers 10.04M GBP.
- 2021-12-31: Trade And Other Current Payables To Trade Suppliers 7.50M GBP.
| Period end | Trade And Other Current Payables To Trade Suppliers |
|---|---|
| 2023-06-30 | 13.99M GBP 6-K · filed 2023-08-10 |
| 2022-12-31 | 11.72M GBP 6-K · filed 2023-08-10 |
| 2022-09-30 | 10.04M GBP 6-K/A · filed 2022-11-18 |
| 2021-12-31 | 7.50M GBP 20-F · filed 2023-03-01 |
| 2020-12-31 | 5.78M GBP 20-F · filed 2022-03-03 |
| 2019-12-31 | 15.73M GBP 20-F · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |